Abstract：
UNASSIGNED: The VIVID (Videos for Addressing Racial Disparities in Implantable Cardioverter Defibrillator Therapy via Innovative Designs) study was a multicenter, randomized controlled trial aimed at evaluating the effectiveness of a video-based decision support tool in enhancing informed consent for implantable cardioverter defibrillator (ICD) implantation among Black patients who met guideline criteria for primary prevention ICDs. Within the broader VIVID randomized trial, a qualitative investigation was conducted to elucidate the decisional factors among Black individuals considering ICD implantation for the primary prevention of sudden cardiac arrest.
UNASSIGNED: Between October 2016 and July 2019, in-depth interviews were conducted at 2 time points from randomization, ≈7 days (time interval for the decision) and at 90 days; the time interval for determining ICD implantation. Interview findings were categorized by randomized groups, those assigned to 1 of the 2 encounter-based video decision support tools or standard care (without video). Interview participants were purposefully selected to ensure diversity across gender, age, educational background, research site, and randomization group; participants were sampled from 14 academic and community-based electrophysiology clinics in the United States. Data analysis employed applied thematic analysis techniques.
UNASSIGNED: A diverse sample of Black individuals were interviewed at 1 week (n=59; female, 37.3%) and 90 days (n=48; female, 39.6%). The primary factors influencing the decisions of Black individuals considering a primary prevention ICD implantation were (1) their clinicians\' recommendations for ICD implantation; (2) their perception of their cardiac health status; and (3) a desire to prolong their lives for the sake of their families.
UNASSIGNED: These findings offer valuable insights that may guide clinicians in their communication with Black patients during shared decision-making encounters related to ICD implantation.
UNASSIGNED: Between October 2016 and July 2019, in-depth interviews were conducted at 2 time points from randomization, ≈7 days (time interval for the decision) and at 90 days; the time interval for determining ICD implantation. Interview findings were categorized by randomized groups, those assigned to 1 of the 2 encounter-based video decision support tools or standard care (without video). Interview participants were purposefully selected to ensure diversity across gender, age, educational background, research site, and randomization group; participants were sampled from 14 academic and community-based electrophysiology clinics in the United States. Data analysis employed applied thematic analysis techniques.
UNASSIGNED: A diverse sample of Black individuals were interviewed at 1 week (n=59; female, 37.3%) and 90 days (n=48; female, 39.6%). The primary factors influencing the decisions of Black individuals considering a primary prevention ICD implantation were (1) their clinicians\' recommendations for ICD implantation; (2) their perception of their cardiac health status; and (3) a desire to prolong their lives for the sake of their families.
UNASSIGNED: These findings offer valuable insights that may guide clinicians in their communication with Black patients during shared decision-making encounters related to ICD implantation.
摘要：
■VIVID（通过创新设计解决植入式心脏复律除颤器治疗中种族差异的视频）研究是一项多中心研究，随机对照试验旨在评估基于视频的决策支持工具在符合一级预防ICD指南标准的Black患者中增强植入式心律转复除颤器(ICD)植入的知情同意方面的有效性.在更广泛的VIVID随机试验中，我们进行了一项定性调查,以阐明考虑植入ICD作为心脏骤停一级预防的黑人个体的决定因素.
■在2016年10月至2019年7月之间，在随机分组的2个时间点进行了深入访谈，≈7天（决定的时间间隔）和90天；确定ICD植入的时间间隔。访谈结果按随机分组进行分类，那些分配给2个基于遭遇的视频决策支持工具或标准护理(无视频)中的1个。面试参与者是有目的地选择的，以确保跨性别的多样性，年龄,教育背景,研究地点,和随机分组;参与者来自美国14个学术和社区的电生理学诊所。数据分析采用了主题分析技术。
■在1周时采访了不同的黑人个体样本（n=59；女性，37.3%)和90天(n=48；女性，39.6%）。影响黑人个体考虑一级预防ICD植入的决定的主要因素是（1）他们的临床医生对ICD植入的建议；（2）他们对自己心脏健康状况的看法；（3）为了家人延长生命的愿望。
■这些发现提供了有价值的见解，可以指导临床医生在与ICD植入相关的共同决策过程中与Black患者进行沟通。
■在2016年10月至2019年7月之间，在随机分组的2个时间点进行了深入访谈，≈7天（决定的时间间隔）和90天；确定ICD植入的时间间隔。访谈结果按随机分组进行分类，那些分配给2个基于遭遇的视频决策支持工具或标准护理(无视频)中的1个。面试参与者是有目的地选择的，以确保跨性别的多样性，年龄,教育背景,研究地点,和随机分组;参与者来自美国14个学术和社区的电生理学诊所。数据分析采用了主题分析技术。
■在1周时采访了不同的黑人个体样本（n=59；女性，37.3%)和90天(n=48；女性，39.6%）。影响黑人个体考虑一级预防ICD植入的决定的主要因素是（1）他们的临床医生对ICD植入的建议；（2）他们对自己心脏健康状况的看法；（3）为了家人延长生命的愿望。
■这些发现提供了有价值的见解，可以指导临床医生在与ICD植入相关的共同决策过程中与Black患者进行沟通。
